Details
Category: Volume 07 Issue 04 April 2019
Hits: 1192

Title: Clinicoepidemiological and mycological study of tinea capitis: A study from a tertiary care centre

Authors: Dr Anjani Kumar Shukla, Dr Bibhuti Bhushan, Dr Dharmendra Kumar Mishra, Dr Shyam Sundar Chaudhary, Dr Ichchhit Bharat, Dr Sukanta Sen

 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.118

Abstract

Background: Dermatophytoses are the most common of the superficial fungal infections. Tinea capitis is a superficial fungal infection that predominantly affects the pediatric population. It is common in tropics and may present in epidemic proportions in areas with high rates of humidity.  The clinicoepidemiological and mycological aspects of this tinea capitis infection were studied in a tertiary care centre in Ranchi, Jharkhand.

Materials & Methods: One hundred sixty patients with positive KOH microscopy were underwent detailed history regarding age, sex, duration and progression of disease socioeconomic status and clinical symptoms and findings were recorded in specifically predesigned proforma. In addition to this a history of similar disease in past, in the family, history of comb sharing, oil application and association with pets was also evaluated.

Results: Most common symptom in the present study was scaling, reported in 94.9% of the patients followed by itching, hair loss, and papules in 78.4%, 69.6%, and 31.6% of the patients respectively. Among the patients with localized scalp involvement, vertex was the most common site involved in 40 (25%) of the patients followed by parietal, occipital, temporal and frontal in 26 (16%), 18(11%), 06(3.7%) and 06 (3.7%) patients respectively.

Conclusion: Grey patch is the most common variant of T capitis. T. violaceum is the most common isolate in all the clinical variants of T capitis in North eastern part of India. Anthropophilic species are responsible mainly for non inflammatory variants and zoophilic species for inflammatory variants. Intra-familial and animal contacts are major source of the source of infection.

Keywords: Tinea capitis, Dermatophytosis, Clinical features, Mycological study.

References

  1. Bhat YJ, Zeerak S, Kanth F, Yaseen A, Hassan I, Hakak R. Clinicoepidemiological and mycological study of tinea capitis in the pediatric population of Kashmir valley: A study from a tertiary care centre. Indian Dermatol Online J 2017; 8:100-3.
  2. Gupta AK, Summerbell RC. Tinea Capitis. Med Mycol 2000; 38:255-87. 
  3. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 4:2-15.
  4. Kundu D, Mandal L, Sen G. Prevalence of Tinea capitis in school going children in Kolkata, West Bengal. J Nat Sci Biol Med. 2012; 3(2):152-5.
  5. Pai VV, Hanumanthayya K, Tophakhane RS, Nandihal NW, Kikkeri NN. Clinical study of Tinea capitis in Northern Karnataka: A three-year experience at a single institute. Indian Dermatol Online J 2013; 4:22-6.
  6. Menan El, Zongo Bonou O, Rouet F, Kiki-barro PC. Tinea capitisin school children from Ivory coast (western Africa) A 1998-1999 cross sectional study. Int J Dermatol. 2002; 41:204–7. 
  7. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50 Suppl 2:6-13.
  8. Sahai S, Mishra D. Change in spectrum of dermatophytes isolated from superficial mycoses cases: First report from Central India. Indian J Dermatol Venereol Leprol 2011;77:335-6.
  1. Kumar V, Sharma RC, Chander R, Clinicomycological study of tinea capitis. Ind J dermatol Venerol 1965; 31:1-5.
  2. Sahgal VN, Saxena AK, Kumari S. Tinea capitis. A clinicoetiologic correlation. Int J Dermatol 1985; 24(2): 116-119.
  3. Hussain I, Muzaffar F, Rashid T, et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol 1999; 37:97–99.
  4. Reddy et al. Clinico-mycological study of tinea capitis in Pondicherry. Ind. J dermatol Venerol 1991; 57: 180-182.
  5. Dastghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: Griseofulvin versus flucon-azole. J Dermatol Treat 2005; 16:43-6.
  6. Lipozencic J, Skerlev M, Orofino-Costa R, et al. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol. 2002; 146:816–823.
  7. Nawaf AM, Joshi A, Zaki A, Nour-Eldin O, Al-Sheltawy M, El-Adawy I, Sharma AK. Tinea capitis among children and adolescents in the Farwaniya region of Kuwait. J Dermatol.2003 Dec;30(12):904-9.
  8. Singal A, Rawat S, Bhattacharya SN, Mohanty S, Baruah MC, Clinicomy-cological profile of tinea captis in North India and response to griseofulvin. J dermatol 2001; 28(1): 22-26.
  9. Figueroa JI, Hawranek T, Abraha A, Hay RJ. Tinea capitis in south-western Ethiopia: a study of risk factors for infection and carriage. Int J Dermatol 1997; 36:661–666.
  10. Bennett ML, Fleisher AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000; 17:304-9.
  11. Verma S, Madhu R. The Great Indian Epidemic of Superficial Dermatophytosis: An Appraisal. Indian J Dermatol. 2017;62(3):227–236.
  12. Gururaj K, Lakshmi N. Tinea capitis in Tirupati, Ind. J. Pathol Microbial 1990; 33: 360-363.

Corresponding Author

Dr Bibhuti Bhushan

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Contact No.: 9932071111